APA (7th ed.) Citation

Zhao, Q., Luo, X., Xing, H., Jiang, C., Ma, J., & Tang, L. (2025). Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate? OncoTargets & Therapy, 18, 1013. https://doi.org/10.2147/OTT.S540295

Chicago Style (17th ed.) Citation

Zhao, Qing, Xiao Luo, Hua Xing, Chengwei Jiang, Jingchao Ma, and Lu Tang. "Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?" OncoTargets & Therapy 18 (2025): 1013. https://doi.org/10.2147/OTT.S540295.

MLA (9th ed.) Citation

Zhao, Qing, et al. "Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?" OncoTargets & Therapy, vol. 18, 2025, p. 1013, https://doi.org/10.2147/OTT.S540295.